Bevacizumab regimen with fluorouracil, folinic acid and irinotecan
Description:
NCI: A first-line chemotherapy regimen consisting of folinic acid (leucovorin), fluorouracil, irinotecan and bevacizumab used for the treatment of advanced-stage colorectal cancer. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)